The impact of the inflammatory response on coagulation - PubMed (original) (raw)
Review
The impact of the inflammatory response on coagulation
Charles T Esmon. Thromb Res. 2004.
Abstract
Inflammation contributions to the thrombotic response involve both cellular and humoral modulation. Inflammation impacts the initiation, propagation and the inhibitory phases of blood coagulation. Inflammatory mediators like endotoxin and tumor necrosis factor alpha (TNF alpha) elicit the expression of tissue factor on blood cells. Under normal circumstance, negatively charged membrane surfaces are limiting so that, even if some activated coagulation factors are generated, propagation of the coagulant stimulus is minimal. Complement activation, however, or exposure of collagen in combination with thrombin, provides a potent stimulus eliciting the exposure of negatively charged phospholipid membrane surfaces. Natural anticoagulant mechanisms limit the thrombotic response, but these pathways are depressed by inflammatory mediators. The protein C pathway is one of the major targets. Thrombomodulin and the endothelial cell protein C receptor are both required for optimal protein C activation, but both are down regulated by inflammatory mediators. Furthermore, free protein S levels often decrease resulting in impaired anticoagulant function of the activated protein C that is generated. In addition, anti-phospholipid antibodies severely impair the protein C pathway further inhibiting this pathway in inflammatory states associated with auto-immunity. In addition to shifting the hemostatic system in favor of clot formation, inflammation elevates the levels of plasminogen activator inhibitor thereby decreasing fibrinolytic activity. The procoagulant impact of inflammation can also be seen at the cellular level. Inflammatory mediators like interleukin 6 can increase both platelet count and their responsiveness to agonists like thrombin. All of these events tend to shift the hemostatic balance in favor of clot formation.
Similar articles
- Crosstalk between inflammation and thrombosis.
Esmon CT. Esmon CT. Maturitas. 2004 Apr 15;47(4):305-14. doi: 10.1016/j.maturitas.2003.10.015. Maturitas. 2004. PMID: 15063484 Review. - Protein C.
Esmon CT. Esmon CT. Prog Hemost Thromb. 1984;7:25-54. Prog Hemost Thromb. 1984. PMID: 6099583 Review. - Inflammation and the activated protein C anticoagulant pathway.
Esmon CT. Esmon CT. Semin Thromb Hemost. 2006 Apr;32 Suppl 1:49-60. doi: 10.1055/s-2006-939554. Semin Thromb Hemost. 2006. PMID: 16673266 Review. - Two-way interactions between inflammation and coagulation.
Levi M, van der Poll T. Levi M, et al. Trends Cardiovasc Med. 2005 Oct;15(7):254-9. doi: 10.1016/j.tcm.2005.07.004. Trends Cardiovasc Med. 2005. PMID: 16226680 Review. - [Protein C and coagulation in sepsis].
D'Angelo A, Della Valle P, Giudici D, Viganò D'Angelo S. D'Angelo A, et al. Minerva Anestesiol. 2004 May;70(5):339-50. Minerva Anestesiol. 2004. PMID: 15181414 Review. Italian.
Cited by
- Complement-Coagulation Cross-talk: Factor H-mediated regulation of the Complement Classical Pathway activation by fibrin clots.
Kang YH, Varghese PM, Aiyan AA, Pondman K, Kishore U, Sim RB. Kang YH, et al. Front Immunol. 2024 Jun 12;15:1368852. doi: 10.3389/fimmu.2024.1368852. eCollection 2024. Front Immunol. 2024. PMID: 38933264 Free PMC article. - Platelet hemostasis in patients with metabolic syndrome and type 2 diabetes mellitus: cGMP- and NO-dependent mechanisms in the insulin-mediated platelet aggregation.
Suslova TE, Sitozhevskii AV, Ogurkova ON, Kravchenko ES, Kologrivova IV, Anfinogenova Y, Karpov RS. Suslova TE, et al. Front Physiol. 2015 Jan 5;5:501. doi: 10.3389/fphys.2014.00501. eCollection 2014. Front Physiol. 2015. PMID: 25601838 Free PMC article. Review. - Understanding, assessing and treating immune, endothelial and haemostasis dysfunctions in bacterial sepsis.
Girardis M, David S, Ferrer R, Helms J, Juffermans NP, Martin-Loeches I, Povoa P, Russell L, Shankar-Hari M, Iba T, Coloretti I, Parchim N, Nielsen ND. Girardis M, et al. Intensive Care Med. 2024 Oct;50(10):1580-1592. doi: 10.1007/s00134-024-07586-2. Epub 2024 Sep 2. Intensive Care Med. 2024. PMID: 39222142 Review. - Role of tumor necrosis factor-α in the extraintestinal thrombosis associated with colonic inflammation.
Yoshida H, Yilmaz CE, Granger DN. Yoshida H, et al. Inflamm Bowel Dis. 2011 Nov;17(11):2217-23. doi: 10.1002/ibd.21593. Epub 2010 Dec 16. Inflamm Bowel Dis. 2011. PMID: 21987296 Free PMC article. - Harmful molecular mechanisms in sepsis.
Rittirsch D, Flierl MA, Ward PA. Rittirsch D, et al. Nat Rev Immunol. 2008 Oct;8(10):776-87. doi: 10.1038/nri2402. Nat Rev Immunol. 2008. PMID: 18802444 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous